PMID- 23762154
OWN - NLM
STAT- PubMed-not-MEDLINE
DCOM- 20130614
LR  - 20211021
IS  - 1741-427X (Print)
IS  - 1741-4288 (Electronic)
IS  - 1741-427X (Linking)
VI  - 2013
DP  - 2013
TI  - Evaluation of the Wound Healing Potential of Resina Draconis (Dracaena 
      cochinchinensis) in Animal Models.
PG  - 709865
LID - 10.1155/2013/709865 [doi]
LID - 709865
AB  - Resina Draconis (RD) is a type of dragon's blood resin obtained from Dracaena 
      cochinchinensis (Lour.) S.C. Chen (Yunnan, China). It has been used as a medicine 
      since ancient times by many cultures. The ethanolic extract of Resina Draconis 
      (RDEE) was evaluated for its wound-healing activity using excision and incision 
      wound models in rats. Group I, the control group, was treated with ointment base. 
      Group II, which served as a reference standard, was treated with moist exposed 
      burn ointment (MEBO). Group III was treated with RDEE. The parameters observed 
      were percentage of wound contraction, epithelialization period, tensile strength, 
      histopathological studies, microvessel density (MVD), and the expression of 
      vascular endothelial growth factor (VEGF) and transforming growth factor- beta 1 
      (TGF- beta 1). The group treated with RDEE showed significantly better wound 
      contraction and better skin-breaking strength as compared with the control group. 
      The results of histopathological examination, MVD, and the expression levels of 
      growth factors supported the outcome of the wound models as well. The present 
      study provided a scientific rationale for the traditional use of RD in the 
      management of wounds.
FAU - Liu, Huihui
AU  - Liu H
AD  - Department of General Surgery, Ninth People's Hospital, Shanghai Jiao Tong 
      University School of Medicine, Shanghai 200011, China.
FAU - Lin, Shaohui
AU  - Lin S
FAU - Xiao, Dan
AU  - Xiao D
FAU - Zheng, Xiao
AU  - Zheng X
FAU - Gu, Yan
AU  - Gu Y
FAU - Guo, Shanyu
AU  - Guo S
LA  - eng
PT  - Journal Article
DEP - 20130516
PL  - United States
TA  - Evid Based Complement Alternat Med
JT  - Evidence-based complementary and alternative medicine : eCAM
JID - 101215021
PMC - PMC3670512
EDAT- 2013/06/14 06:00
MHDA- 2013/06/14 06:01
PMCR- 2013/05/16
CRDT- 2013/06/14 06:00
PHST- 2013/02/05 00:00 [received]
PHST- 2013/04/07 00:00 [revised]
PHST- 2013/04/08 00:00 [accepted]
PHST- 2013/06/14 06:00 [entrez]
PHST- 2013/06/14 06:00 [pubmed]
PHST- 2013/06/14 06:01 [medline]
PHST- 2013/05/16 00:00 [pmc-release]
AID - 10.1155/2013/709865 [doi]
PST - ppublish
SO  - Evid Based Complement Alternat Med. 2013;2013:709865. doi: 10.1155/2013/709865. 
      Epub 2013 May 16.